SCHEMBL23848103

SCHEMBL23848103

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5cccc(-c6cc(-c7ccccc7)nc(-c7ccc(-c8ccccc8)cc7)c6)c5)cc4)cc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.58
▸ KMT2A Q03164 8/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ CYP19A1 P11511 1/20 0.57
▸ ALDH1A1 P00352 5/20 0.50
▸ HPGD P15428 5/20 0.50
▸ MCL1 Q07820 2/20 0.50
▸ ADORA1 P30542 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ ADORA2A P29274 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ CTRC Q99895 1/20 0.49
▸ MAPT P10636 6/20 0.48
▸ NTSR1 P30989 1/20 0.48
▸ MYC P01106 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47
▸ ADORA2B P29275 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ GABRG2 P18507 1/20 0.47
▸ GABRB3 P28472 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14425529 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425521 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425906 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425514 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425858 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL17721000 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL13203398 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425873 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425862 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1
SCHEMBL14425542 1.00 MEN1 (0.58) MEN1KMT2ARAB9ACYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292343-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292343-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, NCL MEN1 828/4885KMT2A 3417/4885RAB9A 1062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback